PotentX Bioscience delivers physician-supervised, evidence-informed regenerative cell therapy for men facing post-surgical erectile dysfunction — through a national network of specialized clinics in New York, California, and Florida.
PotentX Bioscience is a national regenerative medicine company and management services organization (MSO) dedicated to a single, critical mission: restoring neurovascular function and quality of life for men living with post-prostatectomy erectile dysfunction.
Operating through CPOM-compliant physician practice structures across New York, California, and Florida, we deliver a proprietary three-tier therapeutic architecture that addresses the underlying cavernous nerve injury — not merely its symptoms. Every protocol is designed, supervised, and monitored by licensed physicians.
Unlike conventional treatments that manage symptoms, our approach targets the biological mechanisms of neurovascular injury through advanced autologous cellular therapy, growth factor protocols, and evidence-based rehabilitation — individualized to each patient's clinical profile.
More than 300,000 radical prostatectomies are performed annually in the United States. Between 60% and 90% of these patients develop erectile dysfunction as a result of cavernous nerve injury — a distinct neurovascular mechanism that current FDA-approved therapies were not designed to address.
PDE5 inhibitors, vacuum erection devices, and penile implants manage downstream symptoms. No approved intervention targets accessory neural pathway development, cavernous nerve regeneration, or the restoration of functional neurovascular integrity. PotentX was founded to fill that gap.
See Our ApproachPotentX offers a tiered, individualized treatment pathway — from accessible first-line intervention to comprehensive regenerative protocols for complex post-surgical cases. All treatments are physician-prescribed and clinically supervised.
Our physician-formulated nutraceutical is available nationwide via direct subscription — no clinic visit required as a first step. Designed as a supportive neural pathway protocol for post-prostatectomy recovery. Not intended to diagnose, treat, cure, or prevent any disease.
Important: All clinical therapies offered by PotentX Bioscience are physician-prescribed and supervised within a licensed medical practice under applicable state regulations. Autologous cell therapy procedures are performed using a patient's own biological materials in accordance with applicable FDA regulatory frameworks. PotentX does not make claims of FDA approval for investigational cell therapy procedures. Individual results may vary. Consult your physician to determine whether treatment is appropriate for your specific medical condition.
Every patient journey begins with a comprehensive evaluation and concludes with an individualized protocol designed around your specific clinical picture.
Our regenerative protocols are specifically designed for post-surgical sequelae affecting male sexual and urological function. All treatment decisions are made by licensed physicians on an individual patient basis.
Treatment candidacy is determined solely by a licensed physician following a comprehensive clinical evaluation. Not all conditions or patients are appropriate candidates for regenerative cell therapy.
PotentX protocols are built on the established biology of autologous mesenchymal stromal cells (MSCs) — a patient's own therapeutic cells, processed and re-administered under sterile physician supervision. MSCs have demonstrated paracrine signaling capacity, anti-inflammatory activity, and support for angiogenesis and neuroregeneration in published pre-clinical and early clinical studies.
Our NEURO-RESTORE™ formulation targets the nutritional and biochemical precursors associated with accessory neural pathway development — a proprietary framework supported by two provisional patent filings (February 2026).
Explore Our Research LibraryPotentX operates through a legally compliant Management Services Organization (MSO) structure — partnering with independent licensed physician practices to deliver our protocols nationally. Current operations span New York, California, and Florida.
Don't see your state? PotentX is expanding its MSO partner network nationally. Contact us to inquire about clinic availability near you or explore telehealth consultation options for initial evaluation.
Outcomes and experiences are individual. These represent patient perspectives and are not guarantees of results.
PotentX protocols are informed by peer-reviewed research in regenerative biology, urological rehabilitation, and autologous cell therapy. Our growing research library reflects our commitment to evidence-based clinical practice.
Whether you're recently post-surgical or have been managing erectile dysfunction for years, our physicians will conduct a thorough evaluation and present you with a transparent, individualized plan. No commitments. No pressure. Just clinical clarity.